Log In
Print this Print this

BAY 1067197

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionPartial adenosine A1 agonist
Molecular Target Adenosine A1 receptor (ADORA1)
Mechanism of ActionAdenosine A1 receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHeart failure
Indication DetailsTreat heart failure
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today